President and Founder
A strong business leader with proven expertise in both strategy and operations, including entrepreneurial experience, along with a solid research and academic foundation; ability to connect the dots and offer solutions for unmet needs
Thirty years of experience across academics and industry and across geographies; 23 years in the pharmaceutical industry with rich global experience with sponsors and CROs; deep understanding of drug development and entire product lifecycle, including Real World Evidence, Health Economics and Outcomes Research
Combination of qualification in statistics and actuarial science; Over 20 scientific publications in peer-reviewed journals
PhD in Statistics (Stanford University)
Associate, Society of Actuaries (USA)
Chief Medical Officer and Co-founder
Well-recognized thought leader and scientist, with strong research as well as business acumen; extensive experience both in the pharma industry and in academia, research, and clinical practice
Designed and led many early development programs in large pharma; built International Clinical Research Group for a large pharma company to pioneer globalization of clinical trials; Transformed a small biotech at the screening stage into a small pharmaceutical company focused on hospital products for serious infections, while assisting the company through rounds of financing for asset acquisition; played a key role in taking the company public, led NDA submission and EMEA application.
Academic and research experience includes Professorship in Psychiatry, research in pathophysiology of Alzheimer’s disease and contribution to Prevention of AD program at McGill University, Canada.
Over 40 scientific publications in peer-reviewed journals
MD (Université de Liège, Belgium),
Diploma in Psychiatry (McGill University, Canada)
Senior Vice President, Value-based Healthcare
Paul has 30+ years of experience in various roles across research and development, and most recently, across Global Market Access, Peri-Approval, Post-Approval, and Product Development.
Paul spent 17 years at Merck in a variety of roles, the last of which was as Global Market Access Strategy Team Leader for the Oncology franchise. He then spent 4 years at Labcorp Drug Development leading the Phase IV Solutions team before moving to the Market Access Consulting group
Vice President of Real-World Evidence, Market Access & HEOR
Madhur has 12+ years’ experience in healthcare in diverse capacities. He has worked across global, EMEA and JAPAC roles in pharma. He is a market access and pricing strategist with HEOR technical skills.
Madhur has experience with all major payers and HTA’s; across Europe, North America, Middle East and APAC and has developed and executed HEOR, pricing and market access strategy for multiple compounds and for TA’s including: neuroscience, cardiovascular metabolics, immunology, oncology, infectious diseases, diabetes and dermatology. He has managed HEOR, MA & pricing strategy for 2+bn $ per annum portfolio, along-with 20+ SME FTE’s.
Actu-Real offers solutions and services to help payers, providers and pharmaceutical companies optimize objectives of access, quality and cost of healthcare, with the backbone of a fit-for-purpose, all-in-one technology platform for data integration, advanced analytics, reporting and visualization.